advertisement

---

Drug design, development and therapy 12

Showing records 1 to 12 | Display all abstracts in Drug design, development and therapy

126278 Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
Vagiakis I
Drug design, development and therapy 2025; 19: 703-714

---

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Chatzimichail E
Drug design, development and therapy 2025; 19: 2519-2531

---

126278 Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
Papadopoulou EP
Drug design, development and therapy 2025; 19: 703-714

---

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Christodoulaki E
Drug design, development and therapy 2025; 19: 2519-2531

---

126278 Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
Amaxilati E
Drug design, development and therapy 2025; 19: 703-714

---

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Konstas PAG
Drug design, development and therapy 2025; 19: 2519-2531

---

126278 Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
Tsiropoulos GN
Drug design, development and therapy 2025; 19: 703-714

---

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Tsiropoulos GN
Drug design, development and therapy 2025; 19: 2519-2531

---

126278 Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
Konstas AG
Drug design, development and therapy 2025; 19: 703-714

---

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Amaxilati E
Drug design, development and therapy 2025; 19: 2519-2531

---

126278 Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation
Panos GD
Drug design, development and therapy 2025; 19: 703-714

---

126774 Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions
Gugleta K; Gatzioufas Z; Panos GD
Drug design, development and therapy 2025; 19: 2519-2531

---